What amount sold does Lodestone Biomedical, LLC report in Form D filings?

The latest linked filings report $1.2M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Lodestone Biomedical, LLC's most recent SEC filing?

Lodestone Biomedical, LLC's most recent Form D filing was on 2025-07-09.

How many investors does Lodestone Biomedical, LLC have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Lodestone Biomedical, LLC offer?

Lodestone Biomedical, LLC's SEC Form D filings indicate debt offerings.

Lodestone Biomedical, LLC

CIK: 0001710677·Biotechnology·LEBANON, NH·Corporation

Reported Sold

$1,185,000

Total Filings

Identified Offerings

Last Filed

Jul 9, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 9, 2025Form D — New notice

Reported sold: $75,000 · Target: $2,000,000

Rule 506(b)·1 investor

Dec 14, 2021Form D — New notice

Reported sold: $450,000 · Target: $1,000,000

Rule 506(b)·6 investors

Apr 6, 2020Form D — New notice

Reported sold: $110,000 · Target: $400,000

Rule 506(b)·3 investors

Jul 13, 2017Form D — New notice

Reported sold: $550,000 · Target: $600,000

Rule 506(b)·7 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 4 identified offerings

$1,185,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Solomon Diamond

Related Person

Appears on 4 filings

Lidia Valdes

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 9, 2025	New	$2,000,000	$75,000	1
Dec 14, 2021	New	$1,000,000	$450,000	6
Apr 6, 2020	New	$400,000	$110,000	3
Jul 13, 2017	New	$600,000	$550,000	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Accufy Diagnostics, Inc.

Biotechnology

Offering target: $2,000,000

Filed Oct 28, 2026